| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 01/08/2021 | VAL 21/12/21 NF 10689892 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 42 | 0 | 0 | 0 | 0 | 42 |
| 01/08/2021 | VAL 31/07/21 NF 10689882 | Covid-19-Coronavac-Sinovac/Butantan | 10 | 0 | 0 | 0 | 0 | 10 |
| 05/08/2021 | VAL 30/11/21 NF 10757487 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 24 | 0 | 0 | 0 | 0 | 24 |
| 05/08/2021 | VAL 31/07/22 NF 10757487 | Covid-19-Coronavac-Sinovac/Butantan | 10 | 0 | 0 | 0 | 0 | 10 |
| 07/08/2021 | VAL 30/10/21 NF 10772738 | Janssen Covid-19 Vaccine | 5 | 0 | 0 | 0 | 0 | 5 |
| 07/08/2021 | VAL 02/01/22 NF 10772738 | Fiocruz/Oxford/AstraZeneca | 0 | 5 | 0 | 0 | 0 | 5 |
| 07/08/2021 | VAL 30/11/21 NF 10772738 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 30 | 0 | 0 | 0 | 0 | 30 |
| 10/08/2021 | VAL 30/11/21 NF 10804910 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 36 | 0 | 0 | 0 | 0 | 36 |
| 10/08/2021 | VAL 31/07/22 NF 10804910 | Covid-19-Coronavac-Sinovac/Butantan | 10 | 0 | 0 | 0 | 0 | 10 |
| 12/08/2021 | VAL 30/11/21 NF 10828686 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 12 | 0 | 0 | 0 | 0 | 12 |
| 12/08/2021 | VAL 30/06/22 NF 10828586 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 15/08/2021 | VAL 30/11/21 NF 10861272 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 30 | 0 | 0 | 0 | 0 | 30 |
| 20/08/2021 | VAL 08/06/22 NF 10934094 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 7 | 0 | 0 | 0 | 7 |
| 20/08/2021 | VAL 30/09/21 NF 10934094 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 48 | 0 | 0 | 0 | 0 | 48 |
| 20/08/2021 | VAL 31/07/22 NF 10934094 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 20/08/2021 | VAL 31/07/22 NF 10934094 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 20/08/2021 | VAL 31/10/21 NF 10934094 | Fiocruz/Oxford/AstraZeneca | 0 | 90 | 0 | 0 | 0 | 90 |
| 20/08/2021 | VAL 31/07/22 NF 10934094 | Covid-19-Coronavac-Sinovac/Butantan | 30 | 0 | 0 | 0 | 0 | 30 |
| 20/08/2021 | VAL 31/12/21 NF 11229081 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 18 | 0 | 0 | 0 | 0 | 18 |
| 24/08/2021 | VAL 30/09/21 NF 10960180 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 18 | 0 | 0 | 0 | 18 |
| 24/08/2021 | VAL 31/12/21 NF 10960180 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 18 | 0 | 0 | 0 | 0 | 18 |
| 24/08/2021 | VAL 31/07/22 NF 10960180 | Covid-19-Coronavac-Sinovac/Butantan | 10 | 0 | 0 | 0 | 0 | 10 |
| 26/08/2021 | VAL 31/12/21 NF 11003716 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 12 | 0 | 0 | 0 | 0 | 12 |
| 26/08/2021 | VAL 31/0/22 NF 11003716 | Covid-19-Coronavac-Sinovac/Butantan | 30 | 0 | 0 | 0 | 0 | 30 |
| 01/09/2021 | VAL 16/01/22 NF 11064480 | Fiocruz/Oxford/AstraZeneca | 0 | 80 | 0 | 0 | 0 | 80 |
| 01/09/2021 | VAL 31/12/21 NF 11064480 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 6 | 0 | 0 | 0 | 6 |
| 01/09/2021 | VAL 31/07/22 NF 11064480 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 01/09/2021 | VAL 23/07/22 NF 11066232 | Covid-19-Coronavac-Sinovac/Butantan | 8 | 0 | 0 | 0 | 0 | 8 |
| 01/09/2021 | VAL 31/07/21 NF 11066232 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 01/09/2021 | VAL 31/08/22 NF 11066232 | Covid-19-Coronavac-Sinovac/Butantan | 30 | 0 | 0 | 0 | 0 | 30 |
